Indrayani Biotech Ltd.

Indrayani Biotech Ltd.

BBSE:INDRANIB
8.77
INR
+0.09
(+1.04%)
0.48EPS
15.34P/E
329.23MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
137.2
5.92
17.99
47.6
45.81
28.79
30.27
36.63
Basic EPS, GAAP
-0.19
-0.28
-0.35
-0.28
-0.34
-0.15
2.22
-3.15
1.3
2.55
2.87
-1.35
0.47
0.47
Free Cash Flow per Basic Share
-0.18
-0.25
-0.37
-0.28
-0.32
-0.58
6.8
-0.12
0.85
-7.95
-12.86
-1.79
5.44
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
9.21
8.93
-1.02
-1.31
-1.65
-1.8
84.63
5.76
7.06
16.09
14.76
15.92
16.01
16.01
Tangible Book Value per Share
-0.39
-0.67
-1.02
-1.31
-1.65
-1.8
74.1
4.64
5.94
9.27
9.63
10.79
10.88
10.88
Basic Weighted Avg Shares
4
4
4
4
4
4
4
36
34
34
36
45
46
47
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
499
211
616
1,629
1,662
1,302
1,378
1,728
Operating Margin (%)
- -
- -
- -
- -
- -
- -
3.53
-23.29
9.95
8.58
11.94
2.22
3.87
4.11
Depreciation Expense
- -
- -
- -
- -
- -
- -
10
5
7
33
38
34
43
53
Net Income, GAAP
-1
-1
-1
-1
-1
-1
8
-112
44
87
104
-61
22
22
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
0.28
3.05
5.03
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
1.62
-53.18
7.21
5.36
6.27
-4.69
1.57
1.29
Working Capital
- -
- -
- -
- -
- -
- -
55
-27
1
56
579
755
657
657
LT Debt
1
3
4
5
6
6
69
82
73
357
707
654
579
579
Total Equity
34
33
-4
-5
-6
-7
308
201
246
484
763
999
1,021
1,021
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
7.91
- -
15.47
16.2
12.27
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
8.79
- -
15.85
12.83
10.25
- -
- -
- -
Return on Common Equity (%)
-2.03
-3.06
- -
- -
- -
- -
- -
-44.36
20.23
22.05
17.04
-8.74
2.97
3.06

Capital Structure

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
454
- -
704
LT Borrowings
1,009
- -
579
LT Finance Leases
-1
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
46
46
Market Capitalization
563
515
329

Working Capital

INR

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
1,839
- -
1,587
Cash, Cash Equivalents & STI
70
- -
246
Accounts Receivable, Net
623
- -
586
Inventories
432
- -
378
Total Current Liabilities
696
- -
930
Payables & Accruals
- -
- -
- -
ST Debt
454
- -
704
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-456.83%
42.01%
2.19%
Free Cash Flow
-355.39%
-442.9%
-405.19%
Net Income, GAAP
-346.04%
-63.49%
-135.37%
Sales/Revenue/Turnover
- -
68.56%
5.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
423
404
391
444
1,662
2025
315
308
173
506
1,302
2026
291
359
350
728
1,378

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.13
1.62
0.22
0.54
2.87
2025
0.19
0.27
0.05
-1.88
-1.35
2026
0.03
0.2
0.01
0.24
0.47

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Kasiraman Sayee Sundar
Full Time Employees
936
Sector
Consumer services
Industry
Restaurants
Address
SIDCO Electronic Complex Chennai TN India 600032
IPO Date
Feb 14, 1994
Business
Indrayani Biotech Limited operates across diverse sectors, including food and hospitality, dairy, healthcare, pharmaceuticals, engineering, biotechnology, agriculture, and infrastructure. The company strategically grows by acquiring and partnering with established small and medium-sized enterprises across India. Its primary operational divisions encompass Foods and Hospitality, which offers contract food supply services to various institutions; Engineering, covering power electronics and boiler manufacturing; and Healthcare, involving hospitals, clinics, and pharmaceutical operations. Additionally, the company is active in the production of bio-fertilizers and bio-pest controllers through its biotech unit, corporate farming, and the promotion of commercial and residential infrastructure projects. Established on March 9, 1992, the company maintains its headquarters in Chennai, India.